Your AI-Trained Oncology Knowledge Connection!

Armin Ghobadi, MD

Articles

Armin Ghobadi, MD, on Recent Advancements in the Treatment of Patients with DLBCL

January 6th 2021

An expert in the treatment of diffuse large B-cell lymphoma explained some of the exciting advances in treatment and hypothesized what comes next after the 2020 ASH Annual Meeting & Exposition.

Armin Ghobadi, MD, on How to Interpret Preliminary Data in Patients with DLBCL

Armin Ghobadi, MD

January 2nd 2021

Ghobadi expressed caution about interpreting efficacy data from a phase 1 pilot study presented at the 2020 ASH Annual Meeting.

Armin Ghobadi, MD, Discusses Trials Needed to Build on Blinatumomab Pilot Study Data

Armin Ghobadi, MD

December 28th 2020

Ghobadi detailed the next steps needed to build on the results of a study presented at the 2020 American Society of Hematology Annual Meeting & Exposition.

Ghobadi on the Correlation Between CD8/CD4 Ratio and Responses to Blinatumomab in Patients With DLBCL

Armin Ghobadi, MD

December 20th 2020

Ghobadi explained an interesting correlation found in the results of his study presented at the 2020 ASH Annual Meeting & Exposition.

Armin Ghobadi, MD, on Blinatumomab Consolidation Post Stem-Cell Transplant for DLBCL

Armin Ghobadi, MD

December 10th 2020

Research from a pilot trial presented at the 2020 American Society of Hematology (ASH) Annual Meeting found above average complete response and disease-free survival rates for patients with DLBCL.